Public source

Reviewed 11 May 2026

Completeness Fair (28%)

CS-META Algorithm by NucleIQ®

Cells IA

CS-META identifies intestinal metaplasia in esophageal tissue samples, with and without dysplasia, to support cancer diagnosis.

No papers to support — we monitor for new evidence.

General Information

Product name

CS-META Algorithm by NucleIQ®

Company

Modality

Histopathology

Main task

Detection

Subspeciality

Gastrointestinal pathology

Organ/Specimen source

Not specified

Disease targeted

Oesophageal metaplasia

Specimen type

Not specified

Staining

H&E

Stain subtype

Not specified

Regulatory Information

CE-IVD Certification

Pathway:

In Vitro Diagnostic Directive (IVDD)

Class:

General IVD Devices

Not verified by Health AI Register

Scanner Brands Certified for Use (CE-IVD)

Not specified

Scanner Models Certified for Use (CE-IVD)

Not specified

Other certifications

Not specified

Evidence & Research

No research papers or evidence on file yet.

The registry monitors publications for new evidence.

Technical Specifications

Patient population age

Not specified

Input

Not specified

Input format

Not specified

Output

Not specified

Output format

Not specified

Integration

Not specified

Deployment

Not specified

Trigger for analysis

Not specified

Processing time

Not specified

Population

Not specified

Viewer systems

Not specified

Market Presence

On market since

Not specified

AI Platforms

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Not specified

Based on

Not specified

Source: Public | First published: Apr 23, 2026 | Last updated: May 11, 2026

CS-META Algorithm by NucleIQ® - Cells IA